CN102105163B - 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途 - Google Patents

氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途 Download PDF

Info

Publication number
CN102105163B
CN102105163B CN200880130533.4A CN200880130533A CN102105163B CN 102105163 B CN102105163 B CN 102105163B CN 200880130533 A CN200880130533 A CN 200880130533A CN 102105163 B CN102105163 B CN 102105163B
Authority
CN
China
Prior art keywords
somatostatin
seq
cat
chimeric
cow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880130533.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102105163A (zh
Inventor
A·R·门德尔松
K·N·哈费尔
J·拉里克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Braasch Biotech LLC
Original Assignee
Braasch Biotech LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braasch Biotech LLC filed Critical Braasch Biotech LLC
Publication of CN102105163A publication Critical patent/CN102105163A/zh
Application granted granted Critical
Publication of CN102105163B publication Critical patent/CN102105163B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01028—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN200880130533.4A 2008-06-25 2008-06-25 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途 Expired - Fee Related CN102105163B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/068195 WO2009157926A1 (en) 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Publications (2)

Publication Number Publication Date
CN102105163A CN102105163A (zh) 2011-06-22
CN102105163B true CN102105163B (zh) 2014-12-10

Family

ID=41444809

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880130533.4A Expired - Fee Related CN102105163B (zh) 2008-06-25 2008-06-25 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途

Country Status (15)

Country Link
US (3) US7722881B2 (enExample)
EP (1) EP2303314B1 (enExample)
JP (1) JP5506792B2 (enExample)
KR (1) KR101555731B1 (enExample)
CN (1) CN102105163B (enExample)
AU (1) AU2008358353B2 (enExample)
CA (1) CA2728734A1 (enExample)
DK (1) DK2303314T3 (enExample)
ES (1) ES2445403T3 (enExample)
IL (1) IL209792A (enExample)
MX (1) MX2010014082A (enExample)
NZ (1) NZ590011A (enExample)
RU (1) RU2501565C2 (enExample)
WO (1) WO2009157926A1 (enExample)
ZA (1) ZA201009125B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0914300B8 (pt) 2008-06-25 2021-05-25 Braasch Biotech Llc vacina para tratamento de obesidade
CN102105163B (zh) 2008-06-25 2014-12-10 布拉施生物技术有限责任公司 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途
US20150173333A1 (en) * 2012-06-26 2015-06-25 Biovalence Sdn. Bhd. Rapid specific pathogen free animal
US9688723B2 (en) 2012-11-08 2017-06-27 Phi Pharma Sa C4S proteoglycan specific transporter molecules
RU2526571C1 (ru) * 2013-04-08 2014-08-27 Сергей Михайлович Юдин Инъекционный препарат для повышения спермопродукции человека и способ его применения
WO2016029013A2 (en) * 2014-08-21 2016-02-25 Braasch Biotech Llc Methods for improving immunological response in vaccinated animals
WO2021024020A1 (en) 2019-08-06 2021-02-11 Astellas Pharma Inc. Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer
JP7727389B2 (ja) * 2020-02-11 2025-08-21 ブラッシュ・バイオテック・エルエルシー 乳房炎の処置及び／又は予防のための組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0645454A2 (en) * 1993-06-22 1995-03-29 Vladimir Glebovich Lunin Chimeric somatostatin containing protein and coding DNA, immunogenic compositions and method for increasing farm animal productivity
WO2005066344A2 (en) * 2004-01-09 2005-07-21 Instytut Biotechnologii I Antybiotykow New plasmids, their derivatives and fragments, their methods of manufacture and application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
ATE163013T1 (de) * 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
RU2034457C1 (ru) * 1993-06-22 1995-05-10 Товарищество с ограниченной ответственностью "Ветек" Способ повышения продуктивности сельскохозяйственных животных и препарат для его осуществления
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US20070048860A1 (en) * 1997-10-10 2007-03-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Carcinoembryonic antigen (CEA) peptides
US7998930B2 (en) * 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
CA2578626C (en) * 2005-06-27 2011-07-19 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
BRPI0914300B8 (pt) 2008-06-25 2021-05-25 Braasch Biotech Llc vacina para tratamento de obesidade
CN102105163B (zh) * 2008-06-25 2014-12-10 布拉施生物技术有限责任公司 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0645454A2 (en) * 1993-06-22 1995-03-29 Vladimir Glebovich Lunin Chimeric somatostatin containing protein and coding DNA, immunogenic compositions and method for increasing farm animal productivity
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
WO2005066344A2 (en) * 2004-01-09 2005-07-21 Instytut Biotechnologii I Antybiotykow New plasmids, their derivatives and fragments, their methods of manufacture and application

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Ann LEWENDON and William V. SHAW.The PKa of the catalytic histidine residue of chloramphenicol acetyltransferase.《Biochem. J》.1993,第290卷第15-19页. *
Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59;Gary Ott et al.;《Vaccine》;19951231;第13卷(第16期);摘要 *
Gary Ott et al..Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.《Vaccine》.1995,第13卷(第16期),第1557-1562页. *
The PKa of the catalytic histidine residue of chloramphenicol acetyltransferase;Ann LEWENDON and William V. SHAW;《Biochem. J》;19930215;第290卷;摘要，图1-2 *

Also Published As

Publication number Publication date
EP2303314A4 (en) 2012-07-18
AU2008358353B2 (en) 2013-11-07
MX2010014082A (es) 2011-04-07
IL209792A0 (en) 2011-02-28
ZA201009125B (en) 2012-06-27
ES2445403T3 (es) 2014-03-03
IL209792A (en) 2012-12-31
KR20110039517A (ko) 2011-04-19
US7722881B2 (en) 2010-05-25
US7943143B2 (en) 2011-05-17
JP2011525914A (ja) 2011-09-29
NZ590011A (en) 2012-09-28
US20120076806A1 (en) 2012-03-29
DK2303314T3 (da) 2014-01-13
AU2008358353A1 (en) 2009-12-30
BRPI0822826A2 (pt) 2015-07-07
RU2011100104A (ru) 2012-07-20
JP5506792B2 (ja) 2014-05-28
CA2728734A1 (en) 2009-12-30
WO2009157926A1 (en) 2009-12-30
US8367073B2 (en) 2013-02-05
US20100136037A1 (en) 2010-06-03
US20090324629A1 (en) 2009-12-31
EP2303314A1 (en) 2011-04-06
RU2501565C2 (ru) 2013-12-20
CN102105163A (zh) 2011-06-22
KR101555731B1 (ko) 2015-09-25
EP2303314B1 (en) 2013-12-11

Similar Documents

Publication Publication Date Title
CN102105163B (zh) 氯霉素乙酰转移酶(cat)-缺陷型促生长素抑制素融合蛋白及其用途
CA3145228A1 (en) African swine fever vaccine
CN106540248B (zh) 一种抗口蹄疫的疫苗组合物及其制备方法和应用
Zhu et al. Preliminary screening and immunogenicity analysis of antigenic epitopes of spring viremia of carp virus
RU2646137C2 (ru) КОМПОЗИЦИЯ ПО ПРЕДУПРЕЖДЕНИЮ ИНФЕКЦИИ Mycoplasma spp.
US10682398B2 (en) Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
CN111925423B (zh) 一种抗o型口蹄疫的疫苗组合物及其制备方法和应用
WO2010050903A1 (en) Chimeric flagellins for vaccines
CN107625960B (zh) 一种通用型猪大肠杆菌病疫苗及其制备方法
Smooker et al. Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice
US11400151B2 (en) Methods for improving immunological response in vaccinated animals
JP7727389B2 (ja) 乳房炎の処置及び／又は予防のための組成物
KR20190014265A (ko) 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
BRPI0822826B1 (pt) Polipeptídio quimérico com a imunogenicidade da somatostatina, composição imunogênica, composição imunológica, seus usos e métodos nãoterapêuticos para aumentar produção de leite e de carne magra
RU2614115C1 (ru) Рекомбинантный соматостатинсодержащий белок, способ его получения, инъекционный препарат для повышения мясной и молочной продуктивности сельскохозяйственных животных, а также способ использования препарата
US11000579B2 (en) Recombinant Eimeria maxima protein delivered as nanoparticles
CN120365382A (zh) 猪流行性腹泻病毒s蛋白及相关产品
Song et al. Expression of α-β1-β2-ε soluble fusion protein of Clostridium perfringens in Escherichia coli and its immunogenicity in mice.
KR20050036665A (ko) 면역 거세용 재조합 폴리펩타이드 및 이를 포함하는 백신

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141210